Results 191 to 200 of about 27,780 (214)

Provider Role in Transmission of Carbapenem-Resistant Enterobacteriaceae

Infection Control & Hospital Epidemiology, 2017
OBJECTIVEWe sought to evaluate the role healthcare providers play in carbapenem-resistant Enterobacteriaceae (CRE) acquisition among hospitalized patients.DESIGNA 1:4 case-control study with incidence density sampling.SETTINGAcademic healthcare center with regular CRE perirectal screening in high-risk units.PATIENTSWe included case patients with ≥1 ...
Marika E, Grabowski, Hyojung, Kang, Kristen M, Wells, Costi D, Sifri, Amy J, Mathers, Jennifer M, Lobo   +5 more
openaire   +2 more sources

Carbapenem-Resistant Enterobacteriaceae: A Call for Cultural Change

Annals of Internal Medicine, 2014
Starting in 2011, a cluster of infections caused by carbapenem-resistant Enterobacteriaceae (CRE) occurred at the National Institutes of Health Clinical Center.
Tara N, Palmore, David K, Henderson
openaire   +2 more sources

Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections

Current Opinion in Infectious Diseases, 2018
Purpose of review In the absence of randomized clinical trial data, questions remain regarding the optimal treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections. CRE have historically been susceptible to polymyxins, tigecycline or
Tumbarello M., Losito A. R., Giamarellou H.   +2 more
openaire   +2 more sources

Statewide Surveillance of Carbapenem-Resistant Enterobacteriaceae in Michigan

Infection Control & Hospital Epidemiology, 2014
Background.Carbapenem-resistant Enterobacteriaceae (CRE) are clinically challenging, threaten patient safety, and represent an emerging public health issue. CRE reporting is not mandated in Michigan.Methods.The Michigan Department of Community Health–led CRE Surveillance and Prevention Initiative enrolled 21 facilities (17 acute care and 4 long-term ...
Brenda M, Brennan, Joseph R, Coyle, Dror, Marchaim, Jason M, Pogue, Martha, Boehme, Jennie, Finks, Anurag N, Malani, Kerrie E, VerLee, Bryan O, Buckley, Noreen, Mollon, Daniel R, Sundin, Laraine L, Washer, Keith S, Kaye   +12 more
openaire   +2 more sources

Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat

Seminars in Diagnostic Pathology, 2019
The first reports of carbapenem resistance in Enterobacteriaceae isolates occurred in the early 1990s. Researchers published the first report of an isolate that produced Klebsiella pneumoniae carbapenemase in 2001. Since that time, carbapenemase-producing Enterobacteriaceae isolates have disseminated globally.
openaire   +2 more sources

Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?

Virulence, 2017
Sandra S Richter
exaly  

Carbapenem-Resistant Enterobacteriaceae

Amália Raiana Fonseca Lobato, Beatriz Lobato da Silva, Artur Silva, Danielle Murici Brasiliense, Rafael Azevedo Baraúna   +4 more
openaire   +1 more source

Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States

Clinical Microbiology and Infection, 2017
Bruce Lee, B Y Lee
exaly  

CRISPR-Cas9-Mediated Carbapenemase Gene and Plasmid Curing in Carbapenem-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2020
Liang Chen, Liang Chen, Hong Du
exaly  

Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae

Virulence, 2017
Romney Humphries, Ritu Banerjee
exaly